2548
V. Semak et al. / Tetrahedron: Asymmetry 21 (2010) 2542–2549
5.7. General procedure for the cleavage of the 2-hydroxy-1-
phenylethyl moiety from lactams 5, 6, 7a, 9 and 10
NMR (400 MHz, CDCl3, COSY, HSQC) d 0.94 (t, J = 7.5 Hz, 3H,
CH2CH3), 1.66–1.80 (m, 3H, H-4, 2 ꢁ H-5), 1.85 (m, 1H, CH2CH3),
2.07–2.30 (m, 3H, H-3, H-5, 2 ꢁ CH2–CH@), 3.37 (m, 1H, H-6),
5.10 (m, 2H, @CH2), 5.13 (m, 2H, @CH2), 5.70 (m, 1H, CH@), 6.11
(br s, 1H, NH); 13C NMR (100.6 MHz, CDCl3) d 11.8 (CH2CH3), 22.8
(C-4), 24.7 (CH2CH3), 25.0 (C-5), 41.1 (CH2–CH@), 41.7 (C-3), 51.7
In a round bottomed flask equipped with a 1 gallon gas bag of
O2, an excess (10–25 equiv) of freshly ground NaOH was added
to a solution of lactam 5, 6, 7a, 9, or 10 (1 equiv) in MTBE (or
THF). The mixture was heated at 40 °C and stirred slowly at this
temperature for 24 h. The solvent was removed, and the residue
was partitioned between H2O and CH2Cl2. The combined organic
phases were dried and concentrated to give the respective com-
pounds 11–16.
(C-6), 118.8 (@CH2), 133.4 (@CH), 175.4 (NCO); ½a D22
¼ þ20:1
ꢂ
(c 0.63, MeOH); HMRS
C
10H18NO (M++1), 168.1383; found,
180.1382. Anal. Calcd for C10H17NOꢃ1/4H2O: C, 69.93; H, 10.27;
N, 8.16. Found: C, 69.80; H, 10.25; N, 7.98. (3S,6R)-6-Allyl-3-
ethyl-2-piperidin-2-one 3-epi-15. IR (NaCl) 3211, 2933, 1656,
1450 cmꢀ1
; d 0.93
1H NMR (400 MHz, CDCl3, COSY, HSQC)
5.7.1. (R)-6-Methylpiperidin-2-one 114a
(m, J = 7.5 Hz, 3H, CH2CH3), 1.39–1.48 (m, 2H, H-4, H-5), 1.56 (m,
1H, CH2CH3), 1.90–1.98 (m, 3H, H-4, H-5, CH2CH3), 2.09 (m, 1H,
CH2–CH@), 2.18 (m, 1H, H-3), 2.32 (m, 1H, CH2–CH@), 3.37 (m,
1H, H-6), 5.14 (m, 1H, @CH2), 5.18 (m, 1H, @CH2), 5.71 (m, 1H,
CH@), 5.78 (br s, 1H, NH); 13C NMR (100.6 MHz, CDCl3) d 11.0
(CH2CH3), 24.1 (CH2CH3), 25.4 (C-4), 28.9 (C-5), 41.5 (CH2–CH@),
42.2 (C-3), 52.3 (C-6), 119.1 (@CH2), 133.3 (@CH), 174.5 (NCO);
Following the general procedure, from lactam
5 (70 mg,
0.30 mmol) and NaOH (600 mg, 15.0 mmol) in THF (15 mL) for
16 h, 48 mg of a 9:1 mixture of 11 and enamide 17 were obtained.24
This crude mixture (48 mg) in Et2O (25 mL) and 5 N aqueous H2SO4
acid (10 mL) was heated at reflux temperature for 1 h. The mixture
was cooled and diluted with water (15 mL). The aqueous phase
was neutralised to pH 7–8 with NaHCO3 and extracted with EtOAc.
The organic extracts were dried and concentrated. The residue was
purified by column chromatography (1:1 hexane–EtOAc to EtOAc)
to yield lactam 114a (30 mg, 87%). An analytical sample of 17 was ob-
tained from the mixture by column chromatography (1:1 hexane–
EtOAc to EtOAc) (R)-6-Methyl-1-(1-phenylvinyl)piperidin-2-one
½
a 2D2
ꢂ
¼ ꢀ5:4 (c 0.7, MeOH); MS-EI m/z 168 (M++1, 1), 126 (100),
98 (9), 83 (69), 55 (29); HMRS C10H18NO (M++1), 168.1383; found,
180.1381.
5.7.4.1. Epimerisation. Freshly ground NaOH (72 mg, 1.79 mmol)
was added under an inert atmosphere to a solution of 15 (30 mg,
0.18 mmol) in MTBE (1 mL) and the mixture was heated at 40 °C
for 24 h. The solvent was evaporated and the residue was parti-
tioned between H2O and CH2Cl2. The combined organic extracts
were washed with aqueous NH4Cl, dried and evaporated to give
a 1:1 mixture of 15 and 3-epi-15 (23 mg, 77%).
17: IR (NaCl) 2936, 1649 cmꢀ1 1H NMR (400 MHz, CDCl3, COSY,
;
HSQC) d 1.19 (d, J = 7.0 Hz, 3H, CH3), 1.67 (m, 1H, H-5), 1.83 (m, 1H,
H-4), 1.95–2.06 (m, 2H, H-4, H-5), 2.56 (m, 2H, H-3), 3.64 (dd,
J = 11.2, 4.9 Hz, 1H, H-6), 5.22 (s, 1H, C@CH2), 5.84 (s, 1H, C@CH2),
7.31–7.38 (m, 5H, ArH); 13C NMR (100.6 MHz, CDCl3) d 18.4 (C-4),
20.6 (CH3), 30.6 (C-5), 32.7 (C-3), 53.6 (C-6), 113.9 (@CH2), 125.7
(2 ꢁ CHAr), 128.4 (CHAr), 128.5 (2 ꢁ CHAr), 136.1 (C-i), 145.3 (C@),
170.2 (NCO). MS-EI m/z 215 (M+, 100), 186 (40), 172 (40), 118 (40),
103 (53), 77 (47), 55 (38).
5.7.5. 3,3-Diallylpiperidin-2-one 16
Following the general procedure, from lactam 10 (150 mg,
0.5 mmol) and NaOH (200 mg, 5.0 mmol) in MTBE (2.5 mL) for
24 h, compound16(80 mg, 88%)was obtainedafter columnchroma-
tography (1:1 EtOAc–hexanes to EtOAc). IR (NaCl) 3214, 3074, 2936,
5.7.2. (S)-6-Phenyl-2-piperidone 12
Following the general procedure, from lactam 6 (200 mg,
0.68 mmol) and NaOH (270 mg, 6.77 mmol) in THF (3.4 mL) for
24 h, compound 1225 (96 mg, 81%) was obtained.26
1657, 1489 cmꢀ1 1H NMR (400 MHz, CDCl3, COSY, HSQC) d 1.66–
;
1.77 (m, 4H, H-4, H-5), 2.15 (dd, J = 13.5, 8.0 Hz, 2H, CH2–CH@),
2.49 (ddd, J = 13.5, 8.0, 1.0 Hz, 2H, CH2–CH@), 3.21 (m, 2H, H-6),
5.02 (m, 2H, @CH2), 5.06 (m, 2H, @CH2), 5.70–5.81 (m, 2H, CH@),
6.59 (br s, 1H, NH); 13C NMR (100.6 MHz, CDCl3) d 19.4 (C-5), 28.8
(C-4), 42.5 (C-6), 42.7 (2 ꢁ CH2–CH@), 44.7 (C-3), 118.0 (2 ꢁ @CH2),
134.2 (2 ꢁ @CH), 176.3 (NCO); HMRS C11H18NO (M++1), 180.1383;
found, 180.1383.
5.7.3. (6S)-6-[1-(Methoxymethyl)indol-3-yl]piperidin-2-one 13
Following the general procedure, from lactam 7a (185 mg,
0.49 mmol) and NaOH (490 mg, 12.2 mmol) in MTBE (2.5 mL) for
24 h, compound 13 (91 mg, 72%) was obtained after column chro-
matography (99:1 to 98:2 CH2Cl2–MeOH). IR (KBr) 3241, 2953,
1662, 1081 cmꢀ1
;
1H NMR (400 MHz, CDCl3, COSY, HSQC) d 1.83
5.8. (R)-1-Benzoyl-6-methylpiperidin-2-one 1821
(m, 1H, H-4), 1.90–2.03 (m, 2H, H-4, H-5), 2.20 (m, 1H, H-5), 2.49
(m, 2H, H-3), 3.25 (s, 3H, OCH3), 4.91 (dd, J = 7.9, 4.6 Hz, 1H,
H-6), 5.41 (d, J = 2.3 Hz, 2H, NCH2OMe), 6.04 (br s, 1H, NH), 7.13
(s, 1H, H-2ind), 7.17 (t, J = 7.5 Hz, H-5ind), 7.28 (t, J = 7.9 Hz, 1H,
H-6ind), 7.48 (d, J = 8.2 Hz, 1H, H-7ind), 7.59 (d, J = 7.9 Hz, 1H,
H-4ind); 13C NMR (100.6 MHz, CDCl3) d 19.6 (C-4), 30.0 (C-5),
31.4 (C-3), 50.6 (C-6), 56.0 (OMe), 77.4 (NCH2OMe), 110.3
(C-7ind), 117.8 (C-3ind), 118.9 (C-4ind), 120.3 (C-5ind), 122.8
(C-6ind), 125.3 (C-2ind), 126.2 (C-3ind), 137.1 (C-7ind), 172.3
6-Methylpiperidone 11 (100 mg, 0.75 mmol) in THF (1 mL) was
added via cannula to a solution of n-BuLi (0.54 mL of a 1.6 M solu-
tion in hexane, 0.86 mmol) in THF (1 mL) at ꢀ78 °C. After stirring at
ꢀ78 °C for 1.5 h, benzoyl chloride (87
lL, 0.75 mmol) was added
dropwise. The mixture was slowly warmed to rt and stirred for
19 h. Then, the yellowish suspension was poured into a saturated
NH4Cl solution (5 mL) and extracted with Et2O. The combined or-
ganic layers were dried and concentrated, and the resulting residue
was chromatographed (9:1 to 1:1 hexane–EtOAc) to afford 18,
which was crystallised from hexane–EtOAc to give a white solid
(NCO). ½a 2D2
ꢂ
¼ ꢀ55:5 (c 0.6, MeOH); MS-EI m/z 258 (M+, 100), 227
(46), 188 (34), 157 (32), 130 (29); HMRS C15H19N2O2 (M++1),
259.1441; found, 259.1443. Anal. Calcd for C15H18N2O2: C, 69.74;
H, 7.02; N, 10.34. Found: C, 69.24; H, 7.04; N, 10.31.
(80 mg, 53%). IR (NaCl) 2953, 1675 cmꢀ1 1H NMR (400 MHz,
;
CDCl3, COSY, HSQC) d 1.81 (m, 1H, H-5), 1.90 (m, 1H, H-4), 2.02–
2.56 (m, 2H, H-4, H-5), 2.52–2.56 (m, 2H, H-3), 4.53 (m, 1H, H-5),
7.36–7.40 (m, 2H, ArH), 7.44 (m, 1H, ArH), 7.54–7.56 (m, 2H,
ArH); 13C NMR (100.6 MHz, CDCl3) d 17.8 (C-4), 20.3 (CH3), 29.4
(C-5), 34.2 (C-3), 51.6 (C-6), 127.8 (2 ꢁ CHAr), 128.2 (2 ꢁ CHAr),
131.6 (CHAr), 136.4 (C-i), 174.0 (NCO), 174.5 (NCO); mp = 74–
76 °C (hexane–EtOAc); HMRS C13H16NO2 (M++1), 218.1176; found,
218.1174.
5.7.4. (3R,6R)-6-Allyl-3-ethylpiperidin-2-one 15
Following the general procedure, from lactam 9 (200 mg,
0.70 mmol) and NaOH (280 mg, 7 mmol) in MBTE (3.5 mL) for
24 h, a 1:1 mixture of 15 and 3-epi-15 (104 mg, 89%) was obtained.
Epimers were separated by column chromatography (4:1 to 1:1
hexane–EtOAc). 15. IR (NaCl) 3204, 2935, 1663, 1459 cmꢀ1 1H
;